Content funding on Risk.net
Content quality is at the heart of Risk.net’s success. We employ an editorial team of 40 around the globe who are proud of the reputation we have built for objective, in-depth reporting of complex topics.
We often receive enquiries from third parties operating in the markets we cover, who want to align themselves with our quality content. This is natural and forms part of any commercial publisher’s operation. We aim to be fully transparent with our readers, so will always label this content in one of two ways.
Supported by
This content is editorially independent, but has been funded – or part-funded – by a third party that wants to align itself with a subject. This label may appear on an article, a topic, or a section of the site.
In some cases, funding is accepted for work that is already underway; in others, it is accepted for new projects. The funder may suggest topics for coverage, but the relevant commissioning editor is under no obligation to accept those suggestions. The suitability of any funder must first be approved by the editor-in-chief.
The content is written and edited by Risk.net journalists, or those we have approved, using the same processes and standards applied to the rest of our journalism. Risk.net does not show this content to funders for approval.
Sponsor content
This material is paid for by the third party and is produced without the involvement of Risk.net’s editorial team – sometimes it will be written by the third party, and sometimes by a freelance journalist at the direction of the third party. Traditionally, these pieces are known as ‘sponsored statements’ or ‘advertorials’.
All sponsor content is clearly labelled, so any reader of Risk.net can easily distinguish between a piece written by our editorial team and a piece written by a sponsor, in accordance with guidelines set by the Advertising Standards Authority (UK) and the Federal Trade Commission (US).
The acceptance of both ‘supported by’ and ‘sponsor content’ in no way affects our editorial position. Our editorial team works independently from our commercial team, and is free to challenge the activities of companies and organisations that are also our advertisers and sponsors.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net
More on Risk management
Caveat creator: GenAI giants’ pledges won’t pre-empt copyright suits
Tech vendors offer indemnities on generative output, but end-users need to check the fine print, warn IP lawyers
Basel triggers new tussle on anti-Archegos rules
Critics argue new guidelines on counterparty credit risk are either unworkable, or don’t go far enough to tackle concentration and wrong-way risk
Op risk data: TD Bank takes US reg pill in purported drug-related AML fails
Also: SCB fraud bill rising fast; Postbank pain for Deutsche Bank. Data by ORX News
Clear warning on escape hatch for optimisation trades
CCPs fear Emir clearing mandate carve-out for portfolio rebalancing could be abused
One year on, regulators still want a cure for bank runs
Broad support for higher outflow assumptions on uninsured deposits, but that won’t save insolvent banks
Falling T2 balances bode well for eurozone’s stability
Impact of fragmentation would be less severe today than in 2010s, says Marcello Minenna
For a growing number of banks, synthetics are the real deal
More lenders want to use SRTs to offload credit risk, but old hands say they have a long road ahead
Did Fed’s stress capital buffer blunt CCAR?
Experts fear flagship test’s use as a capital top-up has undermined its role in risk management
Most read
- Breaking out of the cells: banks’ long goodbye to spreadsheets
- Too soon to say good riddance to banks’ public enemy number one
- Basel III endgame: why moving fast might prove better for banks